Regulatory acceptance of 3R (replacement, reduction, refinement) testing approaches

  • Email
  • Help

This guideline applies to human and veterinary medicines.

Current effective version

Adopted guideline

Reference numberEMA/CHMP/CVMP/JEG-3Rs/450091/2012
Published22/12/2016
Effective from01/07/2017
Keywords3Rs, regulatory acceptance, testing approaches, non-clinical, quality, human medicinal products, veterinary medicinal products, qualification, validation, replacement, reduction, refinement
DescriptionThis document describes the process for submission and evaluation of a proposal for regulatory acceptance of 3R testing approaches for use in the development and quality control during production of human and veterinary medicinal products. It also presents the scientific and technical criteria for validation of 3R testing approaches and explains the pathways for regulatory acceptance of 3R testing approaches.


Document history

First version

Current version

Adopted guideline

 

Overview of comments

 

Draft guideline


Concept paper

In operation from: 01/07/2017

 

Published: 24/02/2017

 

Published: 03/10/2014


Published: 11/04/2011

Superseded documentPosition paperPublished: 19/02/1997


Related content


How helpful is this page?

Average rating:

 Based on 1 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
1 ratings
0 ratings
0 ratings
    

Tell us more